Lysoway Therapeutics

0 followers


Lysoway Therapeutics has developed unique technological approaches to screen and develop potent modulators of lysosomal ion channels, including TRPML1 and TMEM175. These small-molecule compounds can restore autophagic flux and resolution, as well as enhance plasma membrane repair through direct acti... Read more

Headquarters

Cambridge, US

Employees

1-10

Links

Org chart

Yongchang Qiu
President and CEO

Yongchang Qiu

Collapse
S. Frank Yan
Board Director
Valerie Cullen
Senior Vice President, Head Of Research And Translational Science

Teams

This company has no teams yet